Ribavirin (Inhaled)
An antiviral that is administered via a Small Particle Aerosol Generator (SPAG-2). It is reserved for infants with underlying heart or lung disease.
Dosage by Body Weight
Administered over 12-18 hours daily for 3-7 days in a hospital setting.
- Body Weight
- Infants
- Dose
- Continuous Aerosol
- Frequency
- 12-18 hours/day
- Tracking Notes
- Healthcare workers must take precautions against exposure.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Infants | Continuous Aerosol | 12-18 hours/day | Healthcare workers must take precautions against exposure. |
Formulation
Purpose
Treatment of severe Respiratory Syncytial Virus (RSV) in high-risk infants.
Generic Name
RibavirinBranded Drug Names
Ribavirin (Inhaled) is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.
Alternatives
Safety Advice
Alcohol
CAUTIONRibavirin (Inhaled): Alcohol may worsen dizziness, nausea, dehydration, or liver strain during antiviral treatment. Avoid or limit alcohol.
Pregnancy
SAFE IF PRESCRIBEDRibavirin (Inhaled): Use during pregnancy only when prescribed; treatment may be important for maternal infection control or prevention of transmission.
Breast Feeding
SAFE IF PRESCRIBEDRibavirin (Inhaled): Breastfeeding advice depends on the infection and treatment regimen. Use only with healthcare provider guidance.
Driving
CAUTIONRibavirin (Inhaled): May cause dizziness, fatigue, sleep disturbance, or headache. Avoid driving if alertness is affected.
Liver
CAUTIONRibavirin (Inhaled): Some antivirals can affect liver function or require monitoring in hepatitis, HIV, or severe illness.
Kidney
CAUTIONRibavirin (Inhaled): Several antivirals are cleared by the kidneys and may need dose adjustment or hydration. Consult your healthcare provider.